← Back to Search

Peer Support + Vouchers for Hepatitis C

N/A
Recruiting
Research Sponsored by Carilion Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years or older
Be older than 18 years old
Must not have
Under 18 years old
History of treatment of Hepatitis C infection
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will help researchers understand what keeps people with HCV from getting the treatment they need, and how to better support them.

Who is the study for?
This trial is for adults over 18 with a positive Hepatitis C antibody test and a history of substance use disorder. They must have an elevated Hepatitis C RNA indicating active infection but cannot have had prior treatment for Hepatitis C.
What is being tested?
The study tests whether support from peer specialists and vouchers for phone, transportation, and meals can help people with Hepatitis C engage better in their treatment process, potentially reducing the drop-off between diagnosis and care.
What are the potential side effects?
Since this trial focuses on providing educational resources and logistical support rather than medical interventions, there are no direct side effects from medications being tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 years old.
Select...
I have been treated for Hepatitis C.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Attendance at first appointment
Other study objectives
Semi-structured qualitative interviews

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Peer specialist and VouchersExperimental Treatment1 Intervention
Intervention arm
Group II: Standard of careActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Virginia Polytechnic Institute and State UniversityOTHER
153 Previous Clinical Trials
25,033 Total Patients Enrolled
National Center for Advancing Translational Sciences (NCATS)NIH
369 Previous Clinical Trials
412,792 Total Patients Enrolled
Carilion ClinicLead Sponsor
80 Previous Clinical Trials
15,158 Total Patients Enrolled

Media Library

Peer specialist (PS) and vouchers Clinical Trial Eligibility Overview. Trial Name: NCT05397067 — N/A
Chronic Hepatitis C Research Study Groups: Peer specialist and Vouchers, Standard of care
Chronic Hepatitis C Clinical Trial 2023: Peer specialist (PS) and vouchers Highlights & Side Effects. Trial Name: NCT05397067 — N/A
Peer specialist (PS) and vouchers 2023 Treatment Timeline for Medical Study. Trial Name: NCT05397067 — N/A
~2 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top